SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001062993-14-007294
Filing Date
2014-12-29
Accepted
2014-12-29 16:02:05
Documents
10
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K form10k.htm 10-K 541353
2 EXHIBIT 31.1 exhibit31-1.htm EX-31.1 4393
3 EXHIBIT 32.1 exhibit32-1.htm EX-32.1 2866
10 GRAPHIC consentx1x1.jpg GRAPHIC 1983
  Complete submission text file 0001062993-14-007294.txt   8318086

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE avxl-20140930.xml EX-101.INS 659040
5 XBRL SCHEMA FILE avxl-20140930.xsd EX-101.SCH 265684
6 XBRL CALCULATION FILE avxl-20140930_cal.xml EX-101.CAL 34352
7 XBRL DEFINITION FILE avxl-20140930_def.xml EX-101.DEF 667847
8 XBRL LABEL FILE avxl-20140930_lab.xml EX-101.LAB 1738338
9 XBRL PRESENTATION FILE avxl-20140930_pre.xml EX-101.PRE 734055
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

IRS No.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 000-51652 | Film No.: 141312706
SIC: 8731 Services-Commercial Physical & Biological Research